Our Research Publications
Updated November 2023
Pagination
- Previous page
- Page 37
- Next page
Title | Authors | Year | Journal | Link to Article | Intended Audience Sort descending | Purpose |
---|---|---|---|---|---|---|
Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials | Christou G, Iyengar A, Shorr R, Tinmouth A, Saidenberg E, Maze D, Tay J, Bredeson C, Allan DS | 2016 | Transfusion | View Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials | Health care providers | Clinical research |
Residual Risk of HIV, HCV and HBV in Canada | O'Brien SF, Yi Q-L, Fan W, Scalia V, Goldman M, Fearon MA | 2017 | Transfus Apher Sci | View Residual Risk of HIV, HCV and HBV in Canada | Health care providers | Clinical research |
The cost of transfusing a unit of red blood cells: a costing model for Canadian hospital use | Lagerquist O, Poseluzny D, Werstiuk G, Slomp J, Maier M, Nahirniak S, Clarke G | 2017 | ISBT Sci Ser | View The cost of transfusing a unit of red blood cells: a costing model for Canadian hospital use | Health care providers | Ethical, legal and social implications research |
Circular of information for the use of human blood components: Platelets | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |
Aphérèse thérapeutique | Pavenski K | 2018 | Guide de la pratique transfusionnelle | View Aphérèse thérapeutique | Health care providers | Benchmarking and standard setting |
Concurrence of symmetrical peripheral gangrene and venous limb gangrene following polytrauma: a case report | Tan JH, Mohamad Y, Tan CLH, Kassim M, Warkentin TE | 2018 | J Med Case Rep | View Concurrence of symmetrical peripheral gangrene and venous limb gangrene following polytrauma: a case report | Health care providers | Clinical research |
Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | Chelle P, Yeung CHT, Bonanad S, Morales Munoz JC, Ozelo MC, Megias Vericat JE, Iorio A, Spears J, Mir R, Edginton A | 2019 | J Pharmacokinet Pharmacodyn | View Correction to: Routine clinical care data for population pharmacokinetic modeling: the case for Fanhdi/Alphanate in hemophilia A patients | Health care providers | Clinical research |
Guidelines on the intraoperative transfusion of red blood cells: a protocol for systematic review | Baker L, Park L, Gilbert R, Martel A, Ahn H, Davies A, McIsaac DI, Saidenberg E, Tinmouth A, Fergusson DA, Martel G | 2019 | BMJ Open | View Guidelines on the intraoperative transfusion of red blood cells: a protocol for systematic review | Health care providers | Clinical research |
ResearchUnit: Reducing bleeding after cardiac surgery: fibrinogen concentrate vs cryoprecipitate | Karkouti K | 2020 | Blood.ca website | View ResearchUnit: Reducing bleeding after cardiac surgery: fibrinogen concentrate vs cryoprecipitate | Health care providers | Clinical research |
Comparison of short-term mortality between mechanically ventilated patients with COVID-19 and influenza in a setting of sustainable healthcare system | Lee J, Lee YH, Chang H-H, Choi SH, Seo H, Yoo SS, Lee SY, Cha SI, Park JY, Kim CH | 2020 | J Infect | View Comparison of short-term mortality between mechanically ventilated patients with COVID-19 and influenza in a setting of sustainable healthcare system | Health care providers | Clinical research |
Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology | Bhalla A, Mukherjee M, Radford K, Nazy I, Kjarsgaard M, Bowdish DME, Nair P | 2021 | Allergy | View Dupilumab, severe asthma airway responses, and SARS-CoV-2 serology | Health care providers | Basic research |
High-dose IVIG plus cangrelor platelet "anesthesia" during urgent heparin-CPB in a patient with recent SRA-negative HIT-thrombosis with persisting platelet-activating antibodies | Koster A, Nazy I, Birschmann IE, Smith JW, Sheppard JI, Warkentin TE | 2020 | Res Pract Thromb Haemost | View High-dose IVIG plus cangrelor platelet "anesthesia" during urgent heparin-CPB in a patient with recent SRA-negative HIT-thrombosis with persisting platelet-activating antibodies | Health care providers | Clinical research |
Adverse reactions reporting | Yan M | 2021 | Blood.ca website | View Adverse reactions reporting | Health care providers | Benchmarking and standard setting |
What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Lieberman L, Flegel W, Bodnar M, Clarke G, Hannon J | 2021 | CMAJ Open | View What constitutes the most cautious approach for a pregnant person with weak D type 4.0? | Health care providers | Benchmarking and standard setting |
Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia | Iba T, Levy JH, Warkentin TE | 2022 | Crit Care Med | View Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia | Health care providers | Benchmarking and standard setting |
Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure | Candeliere J, Kirkham AM, Shorr R, Morris G, Berardi P, Seftel MD, Allan DS | 2022 | Cell Ther Transplant | View Systematic Scoping Review of Studies Reporting Unexpected Donor-Derived Abnormalities from Recipients of Allogeneic Hematopoietic Cell Transplantation: A Proposed Framework for Donor Disclosure | Health care providers | New or improved product or process |
Le dépistage bactériologique des plaquettes à la Société canadienne du sang | Khandelwal A, Ramirez-Arcos S, Bigham M | 2022 | Blood.ca website | View Le dépistage bactériologique des plaquettes à la Société canadienne du sang | Health care providers | Benchmarking and standard setting |
FAQ : plasma traité au solvant-détergent (Octaplasma) | Mack J, Gordon I, Romans R, Webert K, Ning S, Zeller M | 2023 | Blood.ca website | View FAQ : plasma traité au solvant-détergent (Octaplasma) | Health care providers | New or improved product or process |
Understanding pulse oximetry in hematology patients: Hemoglobinopathies, racial differences, and beyond | Patterson S, Sandercock N, Verhovsek M | 2022 | Am J Hematol | View Understanding pulse oximetry in hematology patients: Hemoglobinopathies, racial differences, and beyond | Health care providers | Clinical research |
Circular of information for the use of human blood components: Plasma Components | Stewart T | 2023 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation | Tseng E, Crowther MA, Hillis CM | 2016 | CMAJ | View Bridging anticoagulation for interruption of warfarin in a patient with atrial fibrillation | Health care providers | Clinical research |
HDFN and Perinatal Immune Thrombocytopenia | Webert K, Hume H, Revised by Clarke G and Hannon J. | 2015 | Clinical Guide to Transfusion | View HDFN and Perinatal Immune Thrombocytopenia | Health care providers | Other |
IgA deficiency | Goldman M | 2018 | Blood.ca website | View IgA deficiency | Health care providers | Benchmarking and standard setting |
Investigation of acute transfusion reactions | Webert K, Heddle N | 2017 | Practical Transfusion Medicine, 5th Edition | View Investigation of acute transfusion reactions | Health care providers | Benchmarking and standard setting |
Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients | Zeller MP, Arnold DM, Al Habsi K, Cserti-Gazdewich C, Delage G, Lebrun A, Heddle NM | 2017 | Transfusion | View Paroxysmal cold hemoglobinuria: a difficult diagnosis in adult patients | Health care providers | Clinical research |
Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys | Tiller H, Killie MK, Husebekk A, Skogen B, Ni H, Kjeldsen-Kragh J, Olan P | 2012 | Acta Obstet Gyn Scan | View Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys | Health care providers | Clinical research |
Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation | Wiebe C, Nickerson P | 2013 | Curr Opin Organ Transplant | View Posttransplant monitoring of de novo human leukocyte antigen donor-specific antibodies in kidney transplantation | Health care providers | Clinical research |
Reference intervals of complete blood count constituents are highly correlated to waist circumference: Should obese patients have their own “normal values?†| Vuong J, Qiu Y, La M, Clarke G, Swinkels DW, Cembrowski G | 2014 | Am J Hematol | View Reference intervals of complete blood count constituents are highly correlated to waist circumference: Should obese patients have their own “normal values?†| Health care providers | Clinical research |
Sialidase inhibition to increase platelet counts: A new treatment option for thrombocytopenia | Jansen AJG, Peng J, Zhao H-G, Hou M, Ni H | 2015 | Am J Hematol | View Sialidase inhibition to increase platelet counts: A new treatment option for thrombocytopenia | Health care providers | Clinical research |
Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists | Ghadaki B, Nazi I, Kelton JG, Arnold DM | 2013 | Transfusion | View Sustained remissions of immune thrombocytopenia associated with the use of thrombopoietin receptor agonists | Health care providers | Clinical research |
What should men living with severe haemophilia need to know? The perspectives of Canadian haemophilia health care providers | Lane S, Arnold E, Webert KE, Chan A, Walker I, Heddle NM | 2013 | Haemophilia | View What should men living with severe haemophilia need to know? The perspectives of Canadian haemophilia health care providers | Health care providers | Other |
How do we diagnose immune thrombocytopenia in 2018? | Kelton JG VJ, Arnold DM | 2018 | Hematology Am Soc Hematol Educ Program | View How do we diagnose immune thrombocytopenia in 2018? | Health care providers | Clinical research |
Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes | Pierce GF, Iorio A | 2018 | Haemophilia | View Past, present and future of haemophilia gene therapy: From vectors and transgenes to known and unknown outcomes | Health care providers | New or improved product or process |
Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Ragni MV, Croteau SE, Morfini M, Cnossen MH, Iorio A | 2018 | J Thromb Haemost | View Pharmacokinetics and the transition to extended half-life factor concentrates: communication from the SSC of the ISTH | Health care providers | Basic research |
Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Warkentin TE | 2018 | J Thromb Haemost | View Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene | Health care providers | Benchmarking and standard setting |
Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A | Shah A, Solms A, Wiegmann S, Ahsman M, Berntorp E, Tiede A, Iorio A, Mancuso ME, Zhivkov T, Lissitchkov T | 2019 | Ann Hematol | View Direct comparison of two extended-half-life recombinant FVIII products: a randomized, crossover pharmacokinetic study in patients with severe hemophilia A | Health care providers | Clinical research |
Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Hill-Strathy M, Pinkerton PH, Thompson TA, Wendt A, Collins A, Cohen R, WO BC, Cameron T, Lin Y, Lau W, Lieberman L, Callum J | 2021 | Transfusion | View Evaluating the appropriateness of platelet transfusions compared with evidence-based platelet guidelines: An audit of platelet transfusions at 57 hospitals | Health care providers | Clinical research |
Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010–2011 to 2016–2017 | Skowronski DM, Zou M, Clarke Q, Chambers C, Dickinson JA, Sabaiduc S, Olsha R, Gubbay JB, Drews SJ, Charest H, Winter A-L, Jassem A, Murti M, Krajden M, De Serres G | 2020 | Clin Infect Dis | View Influenza Vaccine Does Not Increase the Risk of Coronavirus or Other Noninfluenza Respiratory Viruses: Retrospective Analysis From Canada, 2010–2011 to 2016–2017 | Health care providers | Clinical research |
Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial | Arnold DM, Heddle NM, Cook RJ, Hsia C, Blostein M, Jamula E, Sholzberg M, Lin Y, Kassis J, Larratt L, Tinmouth A, Amini S, Schipperus M, Lim W, Vishnu P, Warner M, Carruthers J, Li N, Lane S, Kelton JG | 2020 | Lancet Haematol | View Perioperative oral eltrombopag versus intravenous immunoglobulin in patients with immune thrombocytopenia: a non-inferiority, multicentre, randomised trial | Health care providers | Clinical research |
Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Hadjesfandiari N, Levin E, Serrano K, Yi Q-L, Devine DV | 2021 | Transfusion | View Risk analysis of transfusion of cryoprecipitate without consideration of ABO group | Health care providers | Benchmarking and standard setting |
Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Stewart T | 2021 | Blood.ca website | View Circular of information for the use of human blood components: Hematopoietic Progenitor Cells (HPC) Cord Blood | Health care providers | Benchmarking and standard setting |
Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Olasupo OO, Lowe MS, Krishan A, Collins P, Iorio A, Matino D | 2021 | Cochrane Database Syst Rev | View Clotting factor concentrates for preventing bleeding and bleeding-related complications in previously treated individuals with haemophilia A or B | Health care providers | Clinical research |
International Forum on Policies and Practice for Transfusion of ABO and RhD Non-Identical Platelets: Summary | Cardigan R, New HV, Estcourt L, Zhiburt E, Dubey R, Bengtsson J, Jöud M, Castillo C, Cid J, Lozano M, Gounder D, Flanagan P, Morley S, Clarke G, Devine D, Hindawi S, AlOtaibi A, Bub CB, Kutner JM, Ikeda T, Goto N, Okazaki H, Fontaine MJ, Pasion J, Song L, Latham T, Kerkhoffs JL, de Haas M, Zwaginga JJ, Gathof BS, Ommer K, Pirenne F, Raba M, Francois A, Daly J, Powley T, Dunbar N | 2022 | Vox Sang | View International Forum on Policies and Practice for Transfusion of ABO and RhD Non-Identical Platelets: Summary | Health care providers | Benchmarking and standard setting |
Novel platelet products including cold-stored platelets | Devine DV | 2022 | Hematology | View Novel platelet products including cold-stored platelets | Health care providers | New or improved product or process |
Investigation of Acute Transfusion Reactions | Leary H, Webert KE, Heddle NM | 2022 | Practical Transfusion Medicine | View Investigation of Acute Transfusion Reactions | Health care providers | Benchmarking and standard setting |
A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy | Dyer C, Alquist CR, Cole-Sinclair M, Curnow E, Dunbar NM, Estcourt LJ, Kaufman R, Kutner JM, McCullough J, McQuilten Z, Potiphar L, Rioux-Masse B, Slichter S, Tinmouth A, Webert K, Yokoyama AP, Stanworth SJ | 2018 | Vox Sang | View A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy | Health care providers | Clinical research |
An enclosed in-gel PCR amplification cassette with multi-target, multi-sample detection for platform molecular diagnostics | Manage DP, Lauzon J, Atrazev A, Chavali R, Samuel RA, Chan B, Morrissey YC, Gordy W, Edwards AL, Larison K, Yanow SK, Acker JP, Zahariadis G, Pilarski LM | 2013 | Lab Chip | View An enclosed in-gel PCR amplification cassette with multi-target, multi-sample detection for platform molecular diagnostics | Health care providers | New or improved product or process |
Blood Administration | de Biasio L, Rymer T | 2017 | Clinical Guide to Transfusion | View Blood Administration | Health care providers | Other |
CMV Seronegative, irradiated, and washed blood components | Prokopchuk-Gauk O, Solh Z | 2016 | Clinical Guide to Transfusion | View CMV Seronegative, irradiated, and washed blood components | Health care providers | Other |
Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses | Heddle NM, Eikelboom J, Liu Y, Barty R, Cook RJ | 2015 | Transfusion | View Exploratory studies on the age of transfused blood and in-hospital mortality in patients with cardiovascular diagnoses | Health care providers | Clinical research |